RxDoctor Payments Data

Teresa Rice, MD

Transplant Surgery · Charleston, SCNPI 1043576101

Payments from drug & device makers

What this record shows

This record is dominated by education: $9,756 of the $13,983 with a category attached, or 69.8%. Intuitive Surgical accounts for 92.4% of it on its own, with 8 other manufacturers making up the rest.

$13,983in general payments, 2019–2025

Across 43 payments — averaging $325.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$13K
  • Davol Inc.$258
  • Sanofi-aventis U.S. LLC$202
  • Organox Ltd$185
  • Integra Lifesciences Corporation$175
  • Veloxis Pharmaceuticals, Inc.$120
  • plus $119 from 3 others

What the payments were for

  • Speaking & faculty fees$5004%
  • Travel & lodging$1,51411%
  • Food & beverage$2,17916%
  • Education$9,75670%
  • Gifts$340%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few transplant surgery providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$111,290
Medicare patients
91
Services billed
277

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Envarsus XrTacrolimus11$17,267
Valganciclovir Hcl71$17,018
Mycophenolate Mofetil19$1,725
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim144$1,250
Famotidine67$905
Prednisone43$284
Carvedilol38$229
Pantoprazole Sodium23$224
Gabapentin43$119
Atorvastatin Calcium21$109
Acyclovir12$90
Tamsulosin Hcl13$69
Amlodipine Besylate12$14

Paid to pharmacies, not to this prescriber.

Other transplant surgery in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →